Seeking Alpha

Hospira's (HSP) quality control problems continue, with the FDA sending the company a warning...

Hospira's (HSP) quality control problems continue, with the FDA sending the company a warning latter about problems at its facility in the southern Indian state of Tamil Nadu. Hospira has faced several regulatory issues since 2010, and earlier this year, it withdrew its 2013 guidance after the FDA blocked the import of some of its products.
From other sites
Comments (1)
  • rambler1
    , contributor
    Comments (678) | Send Message
     
    Time for management to either fix things or get out of Dodge!
    30 May 2013, 09:07 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs